Hepatocellular carcinoma Echocardiography or Ultrasound
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
Overview
On ultrasonography, changes in the liver contour and increased nodularity may be evident. The echo texture may appear coarse along with an increase in echogenicity from focal fatty changes and irregular appearing areas with fibrosis, fatty change, or calcifications.
Echocardiography
Echocardiography
- Echocardiograms may be helpful in the measurement of ejection fraction and identification of ischemic and hypokinetic areas of the ventricles. This is useful in establishing a diagnosis of congestive cardiac failure because of the underlying cause of liver cirrhosis.
- Contrast echocardiography is a useful diagnostic test for hepatopulmonary syndrome:
- Intravenous microbubbles (> 10 micrometers in diameter) from agitated normal saline that are normally obstructed by pulmonary capillaries (normally <8 to 15 micrometers) rapidly transit the lung and appear in the left atrium of the heart within 7 heart beats.
- Intravenous technetium-99m–labeled albumin may transit the lungs and appear in the kidney and brain.
Ultrasound Findings
Ultrasound Findings
- Ultrasound may be helpful in the diagnosis of hepatocellular carcinoma. Findings on an ultrasound suggestive of hepatocellular carcinoma include:[1][2]
- Small hypoechoic lesion with poorly defined margins and coarse irregular internal echoes.
- When the tumor increases in size it appears heterogeneous with fibrosis, fatty change, or calcifications.
- Infiltrative HCC may be difficult to differentiate from background cirrhosis.
Contrast Enhanced Ultrasound
Contrast Enhanced Ultrasound
Contrast-enhanced ultrasound is being adapted for screening and enhancing minimally invasive diagnostic studies. The following phases are noted on the contrast enhanced ultrasonography of hepatocellular carcinoma:[3][4]
| Phases | Findings |
|---|---|
| Arterial phase |
|
| Portal venous phase |
|
References
References
- ↑ Malhi H, Grant EG, Duddalwar V (2014). “Contrast-enhanced ultrasound of the liver and kidney”. Radiol. Clin. North Am. 52 (6): 1177–90. doi:10.1016/j.rcl.2014.07.005. PMID 25444099.
- ↑ “Hepatocellular Carcinoma – W. Y. Lau – Google Books”.
- ↑ Malhi H, Grant EG, Duddalwar V (2014). “Contrast-enhanced ultrasound of the liver and kidney”. Radiol. Clin. North Am. 52 (6): 1177–90. doi:10.1016/j.rcl.2014.07.005. PMID 25444099.
- ↑ Terzi, Eleonora; Salvatore, Veronica; Negrini, Giulia; Piscaglia, Fabio (2015). “Ongoing challenges in the diagnosis of hepatocellular carcinoma”. Expert Review of Gastroenterology & Hepatology. 10 (4): 451–463. doi:10.1586/17474124.2016.1124758. ISSN 1747-4124.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
